Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Louisville › NPI 1861554438

University Medical Center, INC

University Medical Center, INC was paid $179.41M by Medicaid between Jan 2018 and Dec 2024, across 492 billing codes. Its largest line is 99285, emergency room visit (most serious) — 16% of everything it billed.

33Billing provider infoUNIVERSITY MEDICAL CENTER, INC
LOUISVILLE, KY 40202
33aNPI1861554438assigned 12/13/2006
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$179.41M
24GClaims2,408,658
24DCodes billed492
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Student in an Organized Health Care Education/Training Program providers in Kentucky

Rank by total paid#1 of 45
Median peer was paid$14K
This provider vs. median13,121×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018317,093$18.78M
2019329,175$20.40M
2020338,504$24.00M
2021374,946$28.27M
2022384,561$33.12M
2023377,713$31.44M
2024incomplete286,666$23.39M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 59,377 40,921 $27.91M
J9271 Injection, pembrolizumab, 1 mg 11% 2,925 1,950 $19.23M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.8% 55,498 45,059 $12.18M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 4.8% 65,422 52,788 $8.54M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.4% 15,495 12,955 $6.17M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.4% 16,751 8,149 $6.10M
J9299 Injection, nivolumab, 1 mg 2.3% 981 482 $4.16M
96375 Therapeutic injection; each additional sequential IV push 1.9% 28,092 17,997 $3.44M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 34,244 27,166 $3.17M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 16,203 8,413 $2.94M
70450 Computed tomography, head or brain; without contrast material 1.6% 19,279 16,090 $2.87M
77386 1.5% 4,349 378 $2.69M
480 more codes
71260 Computed tomography, thorax, diagnostic; with contrast material 1.5% 11,252 $2.67M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.4% 2,204 $2.55M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.3% 59,798 $2.34M
96417 1.2% 3,663 $2.21M
72125 Computed tomography, cervical spine; without contrast material 1.2% 11,969 $2.20M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 34,795 $2.01M
G0378 Hospital observation service, per hour 1.1% 42,739 $1.97M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.0% 3,271 $1.88M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.0% 1,324 $1.86M
80053 Comprehensive metabolic panel <1% 136,134 $1.76M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,502 $1.75M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 42,283 $1.52M
96415 <1% 3,862 $1.34M
96361 Intravenous infusion, hydration; each additional hour <1% 33,379 $1.21M
71045 Radiologic examination, chest; single view <1% 27,261 $1.15M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 19,181 $1.11M
J0585 Injection, onabotulinumtoxina, 1 unit <1% 1,730 $1.11M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 5,604 $1.03M
78815 Positron emission tomography (PET) for limited area imaging <1% 952 $999K
71046 Radiologic examination, chest; 2 views <1% 16,934 $939K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,777 $907K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,094 $903K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 131,277 $897K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 24,455 $827K
70486 <1% 4,948 $825K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 8,920 $778K
58571 <1% 570 $777K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,530 $774K
J2350 Injection, ocrelizumab, 1 mg <1% 44 $731K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 27,068 $693K
87631 <1% 6,560 $661K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 33,267 $652K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 859 $650K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 14,904 $641K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,344 $633K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,583 $624K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg <1% 556 $604K
70498 <1% 2,081 $592K
77336 <1% 4,159 $576K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 11,796 $565K
96367 <1% 4,811 $564K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 490 $537K
59025 Fetal non-stress test <1% 6,695 $532K
93308 <1% 3,067 $522K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 351 $469K
73030 <1% 6,376 $469K
36224 <1% 101 $467K
96368 <1% 2,307 $442K
36415 Collection of venous blood by venipuncture <1% 105,823 $430K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 11,929 $409K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 8,236 $406K
73630 <1% 6,167 $399K
77067 Screening mammography, bilateral, including computer-aided detection <1% 8,475 $392K
70496 <1% 1,254 $382K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,631 $374K
71250 <1% 1,696 $370K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 9,136 $369K
93975 <1% 1,967 $369K
93971 <1% 1,799 $365K
70491 <1% 1,340 $364K
73610 <1% 7,376 $351K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 22,105 $349K
73590 <1% 6,434 $345K
73552 <1% 4,797 $341K
J2469 Injection, palonosetron hcl, 25 mcg <1% 4,355 $338K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 192 $327K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 126 $317K
73564 <1% 5,248 $315K
96411 <1% 1,419 $312K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 5,501 $297K
73130 <1% 5,876 $289K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,848 $284K
77300 <1% 1,107 $280K
73560 <1% 4,001 $275K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 935 $273K
76770 <1% 2,194 $271K
J2704 Injection, propofol, 10 mg <1% 21,081 $264K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 10,236 $260K
82947 <1% 39,982 $259K
76830 Ultrasound, transvaginal <1% 976 $242K
77334 <1% 958 $239K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,910 $238K
93970 <1% 817 $234K
J1756 Injection, iron sucrose, 1 mg <1% 3,416 $232K
84484 <1% 22,444 $228K
88307 <1% 1,953 $226K
J1453 Injection, fosaprepitant, 1 mg <1% 818 $223K
36226 <1% 57 $222K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 457 $219K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,442 $217K
73110 <1% 4,677 $210K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 495 $203K
87522 Neg quan hep c or qual rna <1% 6,755 $199K
76642 <1% 2,706 $197K
87634 <1% 6,485 $191K
86803 <1% 20,205 $182K
76000 <1% 2,912 $180K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 10,536 $177K
36430 <1% 887 $174K
73090 <1% 3,914 $171K
J0185 Injection, aprepitant, 1 mg <1% 809 $169K
73060 <1% 2,890 $167K
20680 <1% 156 $163K
73502 <1% 3,576 $161K
81268 <1% 952 $161K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 23,321 $159K
84443 Thyroid stimulating hormone (TSH) <1% 11,657 $159K
90715 <1% 6,404 $155K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 7,243 $153K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 18,338 $150K
73080 <1% 2,672 $147K
86850 <1% 16,061 $146K
97161 <1% 3,022 $146K
72131 <1% 850 $145K
72170 <1% 2,407 $143K
97162 <1% 3,668 $143K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 1,185 $139K
88341 <1% 1,020 $138K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 248 $134K
87902 <1% 731 $134K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,827 $134K
80048 Basic metabolic panel (calcium, ionized) <1% 19,613 $133K
99153 Mod sedat endo service >5yrs <1% 1,581 $132K
72100 <1% 1,760 $131K
J7050 Infusion, normal saline solution, 250 cc <1% 10,089 $131K
72190 <1% 1,074 $129K
83690 <1% 28,265 $129K
J1170 Injection, hydromorphone, up to 4 mg <1% 17,658 $126K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,513 $125K
81001 <1% 32,859 $123K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 28,684 $121K
36591 <1% 2,712 $120K
83880 <1% 4,478 $112K
96376 <1% 4,516 $112K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 490 $111K
43235 <1% 175 $111K
77066 Tomosynthesis, mammo <1% 2,308 $110K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 402 $109K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 3,901 $108K
84702 <1% 11,047 $104K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 12,214 $103K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 11,607 $103K
C1769 Guide wire <1% 427 $101K
85610 <1% 27,129 $100K
84703 <1% 15,906 $98K
91200 <1% 1,705 $97K
64642 <1% 861 $97K
97166 <1% 2,029 $95K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion <1% 587 $95K
76536 <1% 742 $95K
88342 <1% 1,790 $94K
96402 <1% 1,528 $94K
73562 <1% 1,347 $93K
J3490 Unclassified drugs <1% 11,198 $92K
83735 <1% 18,035 $92K
88185 <1% 555 $91K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 906 $91K
64488 <1% 167 $90K
10060 <1% 834 $89K
85730 <1% 21,376 $87K
J7120 Ringers lactate infusion, up to 1000 cc <1% 7,835 $86K
J0690 Injection, cefazolin sodium, 500 mg <1% 10,644 $85K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 22,782 $84K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 4,292 $83K
72141 <1% 261 $82K
74018 <1% 1,963 $82K
82805 <1% 1,621 $81K
87808 <1% 8,122 $80K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 19,087 $79K
64643 <1% 508 $78K
36561 <1% 60 $77K
36227 <1% 18 $76K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,993 $74K
73700 <1% 362 $73K
87905 <1% 8,199 $72K
J1650 Injection, enoxaparin sodium, 10 mg <1% 5,685 $70K
12002 <1% 973 $68K
97165 <1% 1,307 $67K
99152 <1% 2,656 $67K
77065 Tomosynthesis, mammo <1% 1,990 $64K
87040 <1% 4,914 $63K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,342 $62K
80074 <1% 1,802 $61K
97022 <1% 4,257 $60K
97116 <1% 2,436 $60K
97602 <1% 1,407 $59K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,661 $58K
86900 <1% 16,029 $56K
81003 <1% 22,042 $56K
64494 <1% 99 $56K
76604 <1% 515 $55K
82565 <1% 4,953 $55K
97168 <1% 1,606 $55K
85027 <1% 10,644 $53K
J0897 Injection, denosumab, 1 mg <1% 28 $53K
86920 <1% 810 $53K
P9016 Red blood cells, leukocytes reduced, each unit <1% 400 $53K
77301 <1% 29 $53K
72128 <1% 263 $53K
J0640 Injection, leucovorin calcium, per 50 mg <1% 881 $52K
82728 <1% 4,706 $52K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 413 $52K
A9573 Injection, gadopiclenol, 1 ml <1% 971 $49K
82607 <1% 4,536 $49K
83605 <1% 5,700 $48K
64493 <1% 131 $47K
86901 <1% 15,977 $47K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 2,942 $47K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,296 $45K
88304 <1% 1,019 $45K
J9190 Injection, fluorouracil, 500 mg <1% 1,299 $45K
J1644 Injection, heparin sodium, per 1000 units <1% 5,011 $44K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,561 $43K
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,409 $42K
80061 Lipid panel <1% 3,271 $42K
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,882 $42K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 3,590 $42K
84100 <1% 12,985 $42K
12001 <1% 739 $40K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 2,957 $40K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,719 $40K
84153 <1% 2,196 $39K
87070 <1% 3,070 $39K
74183 <1% 57 $39K
87075 <1% 4,866 $39K
82550 <1% 7,183 $37K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,458 $37K
70487 <1% 143 $37K
J3480 Injection, potassium chloride, per 2 meq <1% 2,367 $36K
86780 <1% 3,277 $35K
87210 <1% 7,944 $35K
J3475 Injection, magnesium sulfate, per 500 mg <1% 4,014 $34K
77080 <1% 530 $34K
72040 <1% 539 $33K
41899 Unlisted procedure, dentoalveolar structures <1% 53 $33K
87077 <1% 3,906 $32K
82553 <1% 3,220 $32K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,351 $31K
97535 Self-care/home management training, each 15 minutes <1% 1,531 $31K
V2790 Amniotic membrane for surgical reconstruction, per procedure <1% 16 $30K
73070 <1% 700 $29K
76870 <1% 259 $29K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,021 $29K
82746 <1% 2,690 $28K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 11,422 $28K
84466 <1% 3,102 $27K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,499 $27K
88309 <1% 193 $27K
J9045 Injection, carboplatin, 50 mg <1% 831 $26K
J1953 Injection, levetiracetam, 10 mg <1% 1,268 $26K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,520 $25K
J1815 Injection, insulin, per 5 units <1% 2,764 $25K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,112 $24K
C1760 Closure device, vascular (implantable/insertable) <1% 131 $24K
83036 Hemoglobin; glycosylated (A1C) <1% 3,622 $24K
82378 <1% 1,526 $23K
77001 <1% 329 $23K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 118 $23K
J1790 Injection, droperidol, up to 5 mg <1% 3,339 $23K
12011 <1% 354 $22K
84439 <1% 2,223 $21K
72156 <1% 48 $21K
76937 <1% 182 $21K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 50 $21K
88184 <1% 575 $21K
86923 <1% 436 $20K
96523 <1% 1,112 $20K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,754 $20K
83615 <1% 4,283 $19K
86140 <1% 5,149 $19K
76942 <1% 54 $19K
J2060 Injection, lorazepam, 2 mg <1% 4,625 $19K
83520 <1% 1,157 $19K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,477 $19K
36600 <1% 708 $19K
86790 <1% 1,790 $18K
85379 <1% 2,590 $18K
87340 <1% 2,477 $18K
94760 <1% 3,850 $18K
87186 <1% 2,035 $18K
64450 <1% 30 $17K
73600 <1% 453 $17K
83540 <1% 3,352 $17K
76882 <1% 211 $17K
94644 <1% 484 $17K
97760 <1% 681 $17K
86334 <1% 911 $16K
86704 <1% 1,751 $16K
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 267 $16K
74178 <1% 30 $16K
J9267 Injection, paclitaxel, 1 mg <1% 527 $16K
70480 <1% 90 $15K
80164 <1% 1,649 $15K
86706 <1% 1,924 $15K
77338 <1% 63 $15K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,628 $15K
85652 <1% 4,974 $14K
77290 <1% 104 $14K
95874 <1% 1,066 $14K
71101 <1% 219 $13K
80047 <1% 1,361 $13K
64495 <1% 33 $13K
87205 <1% 2,586 $13K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 54 $13K
86480 <1% 243 $13K
84165 <1% 1,214 $12K
87653 <1% 388 $12K
19083 <1% 12 $11K
93017 <1% 87 $11K
L3808 Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment <1% 151 $11K
V2632 Posterior chamber intraocular lens <1% 179 $11K
J1630 Injection, haloperidol, up to 5 mg <1% 3,481 $11K
82105 <1% 910 $10K
74019 <1% 225 $10K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 307 $9K
82803 <1% 738 $9K
64644 <1% 61 $9K
88108 <1% 536 $9K
86038 <1% 715 $8K
C9113 Injection, pantoprazole sodium, per vial <1% 1,187 $8K
71271 <1% 65 $8K
20694 <1% 13 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 236 $8K
82570 <1% 1,812 $8K
73000 <1% 159 $8K
97035 <1% 499 $7K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 167 $7K
88313 <1% 186 $7K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 27 $7K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 68 $7K
J3411 Injection, thiamine hcl, 100 mg <1% 618 $7K
97016 <1% 380 $7K
96409 <1% 35 $6K
76001 <1% 30 $6K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 28 $6K
80178 <1% 989 $6K
88331 <1% 131 $6K
97763 <1% 248 $6K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 39 $5K
84156 <1% 1,952 $5K
85384 <1% 746 $5K
97018 <1% 330 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 306 $5K
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 522 $5K
J3360 Injection, diazepam, up to 5 mg <1% 276 $5K
84166 <1% 243 $5K
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg <1% 21 $4K
73565 <1% 81 $4K
83721 <1% 436 $4K
83970 <1% 109 $4K
87102 <1% 607 $4K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 634 $4K
82784 <1% 216 $4K
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 163 $4K
84550 <1% 889 $4K
86705 <1% 368 $3K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 171 $3K
87428 <1% 72 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 17 $3K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 267 $3K
83550 <1% 1,794 $3K
C1874 Stent, coated/covered, with delivery system <1% 69 $3K
41800 <1% 47 $3K
91065 <1% 13 $3K
86235 <1% 39 $3K
96416 <1% 25 $3K
C1788 Port, indwelling (implantable) <1% 14 $3K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 75 $3K
85048 <1% 536 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 5,603 $3K
73620 <1% 60 $2K
93320 <1% 38 $2K
97597 <1% 37 $2K
86328 <1% 150 $2K
G0008 Administration of influenza virus vaccine <1% 142 $2K
64616 <1% 22 $2K
86146 <1% 51 $2K
82150 <1% 502 $2K
85014 <1% 1,616 $2K
87015 <1% 526 $2K
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 552 $2K
87116 <1% 382 $2K
86147 <1% 59 $2K
97164 <1% 99 $2K
87517 <1% 64 $2K
29125 <1% 55 $2K
73140 <1% 85 $2K
77370 <1% 14 $2K
J2997 Injection, alteplase recombinant, 1 mg <1% 13 $2K
85045 <1% 593 $2K
J1171 Injection, hydromorphone, 0.1 mg <1% 339 $2K
87641 <1% 88 $2K
J1596 Injection, glycopyrrolate, 0.1 mg <1% 335 $2K
A4648 Tissue marker, implantable, any type, each <1% 15 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 604 $2K
72070 <1% 26 $2K
88302 <1% 55 $2K
J8540 Dexamethasone, oral, 0.25 mg <1% 1,036 $2K
J9263 Injection, oxaliplatin, 0.5 mg <1% 45 $1K
93356 <1% 13 $1K
0001A <1% 69 $1K
J3489 Injection, zoledronic acid, 1 mg <1% 83 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 164 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 752 $1K
86160 <1% 39 $1K
J9060 Injection, cisplatin, powder or solution, 10 mg <1% 80 $1K
86922 <1% 13 $1K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 143 $1K
87081 <1% 157 $966.32
87206 <1% 351 $952.20
84145 <1% 62 $931.79
85049 <1% 355 $927.03
88173 <1% 60 $914.24
J3486 Injection, ziprasidone mesylate, 10 mg <1% 14 $837.20
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 297 $828.47
77417 <1% 28 $811.84
86200 <1% 44 $779.53
0031A <1% 27 $722.36
89051 <1% 114 $657.34
90686 <1% 249 $624.22
83010 <1% 82 $622.30
90674 <1% 76 $580.90
J1920 Injection, labetalol hydrochloride, 5 mg <1% 72 $542.43
J1805 Injection, esmolol hydrochloride, 10 mg <1% 81 $530.95
99426 <1% 15 $516.58
J0735 Injection, clonidine hydrochloride, 1 mg <1% 38 $497.05
88311 <1% 48 $490.20
94010 <1% 16 $470.80
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 143 $435.41
95700 <1% 16 $410.23
J1956 Injection, levofloxacin, 250 mg <1% 31 $340.17
73100 <1% 16 $336.29
82248 <1% 76 $331.27
82140 <1% 41 $306.27
82010 <1% 55 $304.60
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 243 $304.48
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing <1% 19 $302.00
82247 <1% 58 $295.58
86255 <1% 46 $290.32
87640 <1% 14 $285.97
86787 <1% 36 $277.77
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 20 $271.46
86141 <1% 45 $257.69
83497 <1% 25 $243.23
J2359 Injection, olanzapine, 0.5 mg <1% 17 $235.73
97139 <1% 39 $234.64
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 114 $205.52
85018 <1% 62 $201.93
J0670 Injection, mepivacaine hydrochloride, per 10 ml <1% 32 $196.89
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 13 $187.70
51798 <1% 18 $185.01
87556 <1% 17 $180.02
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 14 $173.71
87147 <1% 52 $166.08
12013 <1% 15 $164.16
J0360 Injection, hydralazine hcl, up to 20 mg <1% 28 $157.49
86709 <1% 14 $155.20
86376 <1% 13 $143.34
87449 <1% 19 $134.06
A9270 Non-covered item or service <1% 1,946 $133.60
L3931 Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment <1% 93 $132.66
J2780 Injection, ranitidine hydrochloride, 25 mg <1% 33 $132.13
82525 <1% 20 $124.92
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 14 $82.16
86431 <1% 17 $72.35
J1836 Injection, metronidazole, 10 mg <1% 18 $69.26
82945 <1% 12 $48.50
84157 <1% 12 $45.30
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 59 $29.14
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 36 $25.20
80341 <1% 12 $14.83
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 24 $10.03
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 18 $0.15
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg <1% 44 $0.07
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 14 $0.00
91300 0% 157 $0.00
80334 0% 12 $0.00
80326 0% 12 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 24 $0.00
80331 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTRACK, KIRK (CFO)
Same official

Other billing entities under STRACK, KIRK

Full network →
ProviderLocationPaid
Uofl Health-Louisville INCLouisville, KY$283.15M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.